Dr. Austin Jay Fernstrum, MD

Dr. Fernstrum practices at Bronson Methodist Hospital in Kalamazoo, Michigan, part of Bronson Healthcare Group.

Dr. Fernstrum's NPI, 1952763153, was assigned on March 25, 2016. Dr. Fernstrum graduated from Michigan State University College of Human Medicine in 2016. Dr. Fernstrum holds Michigan license 4301506846.

Dr. Fernstrum's primary practice is Bronson Methodist Hospital, at 601 John Street, Kalamazoo, MI 49007 in Kalamazoo County. The practice phone is (269) 341-6000.

Dr. Fernstrum's primary practice is Bronson Methodist Hospital in Kalamazoo, Michigan, part of Bronson Healthcare Group. Dr. Fernstrum is also affiliated with Beacon Kalamazoo. The medical group on file is Bronson Medical Group. Dmand AI also links Dr. Fernstrum to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fernstrum practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Fernstrum's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Fernstrum is licensed in Michigan.

CMS data shows 677 Medicare services from Dr. Fernstrum across 13 procedure codes in 2024, for 347 Medicare patients. Medicare paid $52,975 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 347 Medicare patients who saw Dr. Fernstrum in 2024. The largest group is 65 to 74, with 179 patients. 74% of them have high cholesterol, and 69% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fernstrum's median patient age at 73, with 20% women.

In 2024, Dr. Fernstrum wrote 1,364 Medicare Part D claims for 612 patients. 93% of them were for generic drugs. CMS names the drug for 1,299 of them, across 18 drugs with 11 or more claims each, at $53,087 in total drug cost. In 2023, CMS named 631 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Fernstrum for performance year 2024, reported as part of a group. Dr. Fernstrum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 38 procedures of prostate resection by Dr. Fernstrum, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Fernstrum, published from 2019 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Prostatic Neoplasms and Prostatic Hyperplasia. Dr. Fernstrum has published most often in Urology. Dr. Fernstrum's most frequent co-authors are Laura Bukavina, MD, Lee E. Ponsky, MD and Adam Christopher Calaway, MD.

CMS Open Payments shows 135 general payments to Dr. Fernstrum from 34 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 61% of the total. Boston Scientific Corporation paid the most, $2,581.

Dr. Fernstrum graduated from Michigan State University College of Human Medicine in 2016.